Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations andDisclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medplus Health Services has informed the stock exchanges that its subsidiary, Optival Health Solutions Private Limited, received a suspension order for the Drug License of a store located at Naagaram, Telangana. The order was issued by the Assistant Director, Drugs Control Administration, Shameerpet, under Rule 65 of the Drugs and Cosmetics Act, 1940, and was received on June 16, 2025. The suspension is for a period of five days. The company estimates a potential revenue loss of approximately Rs 5.97 lakhs due to this suspension.
The financial impact is minimal at around Rs 5.97 lakhs, limited to a single store and a short 5-day suspension, so it is unlikely to materially affect the company's overall operations or stock price.